Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

British Journal of Cancer
Veerle M H CoupéC J L M Meijer

Abstract

We determined the prevalence of type-specific hrHPV infections in the Netherlands on cervical scrapes of 45 362 women aged 18-65 years. The overall hrHPV prevalence peaked at the age of 22 with peak prevalence of 24%. Each of the 14 hrHPV types decreased significantly with age (P-values between 0.0009 and 0.03). The proportion of HPV16 in hrHPV-positive infections also decreased with age (OR=0.76 (10-year scale), 95% CI=0.67-0.85), and a similar trend was observed for HPV16 when selecting hrHPV-positive women with cervical intraepithelial neoplasia grade 2 or worse (CIN2+) (OR=0.76, 95% CI=0.56-1.01). In women eligible for routine screening (age 29-61 years) with confirmed CIN2+, 65% was infected with HPV16 and/or HPV18. When HPV16/18-positive infections in women eligible for routine screening were discarded, the positive predictive value of cytology for the detection of CIN2+ decreased from 27 to 15%, the positive predictive value of hrHPV testing decreased from 26 to 15%, and the predictive value of a double-positive test (positive HPV test and a positive cytology) decreased from 54 to 41%. In women vaccinated against HPV16/18, screening remains important to detect cervical lesions caused by non-HPV16/18 types. To maintain a ...Continue Reading

References

Mar 7, 2002·Journal of Clinical Microbiology·Adriaan J C van den BrulePeter J F Snijders
Nov 22, 2002·The New England Journal of Medicine·Laura A KoutskyUNKNOWN Proof of Principle Study Investigators
Jan 25, 2003·American Journal of Epidemiology·Rachel L WinerLaura A Koutsky
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Oct 2, 2003·Sexually Transmitted Diseases·Silvia de SanjoseF Xavier Bosch
Apr 1, 2004·International Journal of Cancer. Journal International Du Cancer·Nicole W J BulkmansChris J L M Meijer
Jan 22, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Guglielmo RoncoSilvia Franceschi
Jan 21, 2006·Cancer Research·Philip E CastleRobert D Burk
Apr 6, 2006·International Journal of Cancer. Journal International Du Cancer·Jack CuzickThomas Iftner
Sep 23, 2006·International Journal of Cancer. Journal International Du Cancer·Silvia FranceschiNubia Muñoz

❮ Previous
Next ❯

Citations

May 29, 2009·Cancer Causes & Control : CCC·Richard A MooreAngela Brooks-Wilson
Oct 27, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Julia W GarganoElizabeth R Unger
Feb 1, 2013·BMC Infectious Diseases·Elena ArgyriEfstathia Panotopoulou
Jul 3, 2013·Infectious Agents and Cancer·Ying JiangHoward Morrison
Feb 6, 2010·Expert Opinion on Biological Therapy·Anne Szarewski
Mar 13, 2010·BMC Infectious Diseases·Anneli UuskülaJack DeHovitz J
Feb 9, 2010·Journal of the National Cancer Institute·Nubia MuñozRichard M Haupt
Dec 22, 2015·International Journal of Cancer. Journal International Du Cancer·S Rachel SkinnerUNKNOWN VIVIANE Study Group
Jan 19, 2017·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Guorui ZhangYang Xiang
Dec 9, 2014·International Journal of Cancer. Journal International Du Cancer·Margaretha A VinkJohannes Berkhof
Jun 13, 2012·International Journal of Cancer. Journal International Du Cancer·Anneke SteensHester E de Melker
Feb 19, 2014·Journal of Epidemiology and Global Health·Ariane BauduMariette Mercier
Nov 30, 2018·Diagnostic Cytopathology·Hongxia SunVijayalakshmi Padmanabhan
Dec 21, 2011·Sexually Transmitted Diseases·Henrike J VriendUNKNOWN Municipal Health Services
Jul 25, 2008·BJOG : an International Journal of Obstetrics and Gynaecology·D A M HeidemanC J L M Meijer
Nov 28, 2008·International Journal of Cancer. Journal International Du Cancer·Veerle M H CoupéJohannes Berkhof
Feb 20, 2018·Virology Journal·Monique Figueiredo TeixeiraAdele Schwartz Benzaken
Jan 30, 2010·International Journal of Cancer. Journal International Du Cancer·Johannes BerkhofChris J Meijer
Aug 15, 2012·Current Oncology Reports·Anne Szarewski
Aug 6, 2011·Advances in Therapy·Sherri N Sheinfeld GorinRebecca B Perkins
Jan 28, 2020·The Journal of Infectious Diseases·Irene ManJohannes A Bogaards
Jan 30, 2016·PloS One·Steffie K NaberMarjolein van Ballegooijen
Dec 31, 2010·International Journal of Cancer. Journal International Du Cancer·Tiina PetäjäDominique Descamps
Apr 15, 2011·International Journal of Cancer. Journal International Du Cancer·Richard M HauptUNKNOWN FUTURE I and II Investigators
Mar 15, 2011·International Journal of Cancer. Journal International Du Cancer·Dorien C RijkaartChris J L M Meijer
Jul 16, 2016·Sexually Transmitted Diseases·Wouter B van der SluisMargriet G Mullender

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
biopsy

Clinical Trials Mentioned

ISRCTN20781131

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.